IMVT
Immunovant, Inc. · Healthcare
Roivant Sciences Ltd. bought $350.0M of Immunovant, Inc.
Director and 10% owner
Bought$349,999,986
$21.00Price
16,666,666Shares
+17%Stake
What IMVT did for a copier
- $1,000 copied at Mon, Dec 15 open, $26.73
- $990
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the Jan 29 close.
Roivant Sciences Ltd.'s record
14 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Dec 12. Filed Fri, Dec 12, 5:17 PM ET, after the close. Returns use the Dec 15 open and the Jan 29 close. Not investment advice.